Global Health Technology chosen to present at DNB HCC Venture Session, again.

For the second year in a row we are chosen to present at the Venture session at the DNB Healthcare Conference 2021 held the 16th of december.
Together with 11 Norwegian startups and scaleups within pharma, bio and medtech, we will present our groundbreaking solution within stoma and wound care, based on our patents. It is a great honor to be invited back to this event, and I really look forward to meet the other promising finalists, says BDM Alf Erik Malm.

The jury consisted of Investinor, DNB, Norway Health Tech and SANDS.

More information about the event is available here: https://www.norwayhealthtech.com/event/dnb-healthcare-conference-2021/

Forrige
Forrige

Epidermolysis Bullosa: Erland Care Protective Skin gets full reimbursement in Norway

Neste
Neste

HELFO gives full reimbursment on Aquaflush Irrigation system.